Filed: 11/14/2022ACC: 0000950123-22-012070
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $273.1K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$273.1K
Total AUM (reported)
42.16M
Total Shares
Allocation by class
COMMON STOCK$234.3K85.8%
COMMON STOCK CLASS A$38.7K14.2%
Portfolio Concentration
Top 3$153.3K56.1%
4–10$94.3K34.5%
11–25$25.5K9.3%
Top 3 weight
56.1%
Top 10 weight
90.7%
Voting Authority Distribution
Total shares with voting rights: 42.16M
Sole
Full voting authority
42.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
Replimune Group
SOLEShares4.29M
TypeSH
Market value$74.1K
27.12%
Sole
4.29M
Shared
0.00
None
0.00
Imago Biosciences
SOLEShares3.02M
TypeSH
Market value$45.4K
16.64%
Sole
3.02M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares15.07M
TypeSH
Market value$33.8K
12.36%
Sole
15.07M
Shared
0.00
None
0.00
Cincor Pharma
SOLEShares560.99K
TypeSH
Market value$18.4K
6.74%
Sole
560.99K
Shared
0.00
None
0.00
Gossamer Bio
SOLEShares1.50M
TypeSH
Market value$18.0K
6.58%
Sole
1.50M
Shared
0.00
None
0.00
Morphic Holding
SOLEShares597.72K
TypeSH
Market value$16.9K
6.19%
Sole
597.72K
Shared
0.00
None
0.00
Alpine Immune Sciences
SOLEShares2.03M
TypeSH
Market value$14.6K
5.35%
Sole
2.03M
Shared
0.00
None
0.00
Kronos Bio
SOLEShares3.82M
TypeSH
Market value$12.8K
4.68%
Sole
3.82M
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$8.0K
2.92%
Sole
2.25M
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$5.7K
2.07%
Sole
1.79M
Shared
0.00
None
0.00
Paratek Pharmaceuticals
SOLEShares1.97M
TypeSH
Market value$5.1K
1.86%
Sole
1.97M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$5.1K
1.85%
Sole
843.75K
Shared
0.00
None
0.00
Omega Alpha SPAC
SOLEShares501K
TypeSH
Market value$5.0K
1.82%
Sole
501K
Shared
0.00
None
0.00
Theseus Pharmaceuticals
SOLEShares711.48K
TypeSH
Market value$4.1K
1.51%
Sole
711.48K
Shared
0.00
None
0.00
Spruce Biosciences
SOLEShares2.16M
TypeSH
Market value$3.0K
1.08%
Sole
2.16M
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$1.6K
0.59%
Sole
251.27K
Shared
0.00
None
0.00
Jounce Therapeutics
SOLEShares275.51K
TypeSH
Market value$645.00
0.24%
Sole
275.51K
Shared
0.00
None
0.00
ESSA Pharma
SOLEShares328.20K
TypeSH
Market value$597.00
0.22%
Sole
328.20K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
SOLEShares195.79K
TypeSH
Market value$425.00
0.16%
Sole
195.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Replimune GroupSOLE | Common Stock | 4.29M | SH | $74.1K 27.12% | 4.29M | 0.00 | 0.00 |
Imago BiosciencesSOLE | Common Stock | 3.02M | SH | $45.4K 16.64% | 3.02M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 15.07M | SH | $33.8K 12.36% | 15.07M | 0.00 | 0.00 |
Cincor PharmaSOLE | Common Stock | 560.99K | SH | $18.4K 6.74% | 560.99K | 0.00 | 0.00 |
Gossamer BioSOLE | Common Stock | 1.50M | SH | $18.0K 6.58% | 1.50M | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 597.72K | SH | $16.9K 6.19% | 597.72K | 0.00 | 0.00 |
Alpine Immune SciencesSOLE | Common Stock | 2.03M | SH | $14.6K 5.35% | 2.03M | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 3.82M | SH | $12.8K 4.68% | 3.82M | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $8.0K 2.92% | 2.25M | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $5.7K 2.07% | 1.79M | 0.00 | 0.00 |
Paratek PharmaceuticalsSOLE | Common Stock | 1.97M | SH | $5.1K 1.86% | 1.97M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $5.1K 1.85% | 843.75K | 0.00 | 0.00 |
Omega Alpha SPACSOLE | Common Stock Class A | 501K | SH | $5.0K 1.82% | 501K | 0.00 | 0.00 |
Theseus PharmaceuticalsSOLE | Common Stock | 711.48K | SH | $4.1K 1.51% | 711.48K | 0.00 | 0.00 |
Spruce BiosciencesSOLE | Common Stock | 2.16M | SH | $3.0K 1.08% | 2.16M | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $1.6K 0.59% | 251.27K | 0.00 | 0.00 |
Jounce TherapeuticsSOLE | Common Stock | 275.51K | SH | $645.00 0.24% | 275.51K | 0.00 | 0.00 |
ESSA PharmaSOLE | Common Stock | 328.20K | SH | $597.00 0.22% | 328.20K | 0.00 | 0.00 |
Senti Biosciences, Inc.SOLE | Common Stock | 195.79K | SH | $425.00 0.16% | 195.79K | 0.00 | 0.00 |